Briumvi’s Phase 3 trial of an at-home injection has completed enrollment, testing an under-the-skin version against IV ...
For decades, the treatment of developmental and epileptic encephalopathies has focused on suppressing seizures rather than modifying the underlying biology of disease. In the New England Journal of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results